Wednesday, February 09, 2022

COCA Call Tomorrow (Feb 10th) :Multisystem Inflammatory Syndrome in Children (MIS-C)


 

#16,557
While it is true that most children appear to only suffer mild to moderate illness with SAR-CoV-2 infection, as of late January (see CDC chart below) more than 7,142 kids in the United States have been diagnosed with a severe, life-threatening autoimmune response dubbed MIS-C.



According to the CDC's MIS Website: 
Multisystem inflammatory syndrome (MIS) can affect children (MIS-C) and adults (MIS-A). MIS is a rare but serious condition associated with COVID-19 in which different body parts become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs.
This syndrome was first identified in the spring of 2020, and prompted a CDC HAN (see CDC HAN: Multisystem Inflammatory Syndrome In Children (MIS-C)), and a COCA call (see Multisystem Inflammatory Syndrome in Children (MIS-C)) in May of that year. 
We've revisited the topic a number of times since then, including:

MMWR: Multisystem Inflammatory Syndrome in Adults (MIS-A) Associated With SARS-CoV-2 Infection

CHOP Research: COVID-linked MIS-C Associated with Myocardial Injury

J. Peds: Pediatric SARS-CoV-2: Clinical Presentation, Infectivity, and Immune Responses

Tomorrow (Feb 10th) the CDC will update clinicians on what has been learned about MIS-C in a 1-hour COCA call. These presentations are often technical, and are of greatest interest to clinicians and healthcare providers, but also may be of interest to the general public. 
As always, If you are unable to attend the live presentation, these (and past) webinars are archived and available for later viewing at this LINK.
Details on tomorrow's presentation follows:

COVID-19 Updates: What Clinicians Need to Know About Multisystem Inflammatory Syndrome in Children

Free Continuing Education

Overview

Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe condition associated with SARS-CoV-2 infection. The Centers for Disease Control and Prevention (CDC) has been actively involved in MIS-C surveillance and research, and development of MIS-C resources to support the public health and healthcare community. During this COCA Call, presenters will discuss CDC’s surveillance of MIS-C, updated MIS-C resources for healthcare providers, research that informed those resources, and data related to COVID-19 vaccination and MIS-C.

Presenters

Angela Campbell, MD, MPH, FAAP, FPIDS, FIDSA
Medical Officer
Multisystem Inflammatory Syndrome (MIS) Unit
COVID-19 Response
Centers for Disease Control and Prevention

Shana Godfred-Cato, DO, FAAP
Medical Officer
Multisystem Inflammatory Syndrome (MIS) Unit
COVID-19 Response
Centers for Disease Control and Prevention

Anna Yousaf, MD
Medical Officer
Multisystem Inflammatory Syndrome (MIS) Unit
COVID-19 Response
Centers for Disease Control and Prevention

Call Materials

None at this time
Call Details

When:
Thursday, February 10, 2022,
2:00 PM – 3:00 PM ET


Webinar Link:
https://www.zoomgov.com/j/1606170121external icon

Passcode: 731625

Dial In:
US: +1 669 254 5252
or +1 646 828 7666
or +1 669 216 1590
or +1 551 285 1373

International numbersexternal icon

One-tap mobile:
US: +16692545252,,1606170121#,,,,*731625# or +16468287666,,1606170121#,,,,*731625#

Webinar ID: 160 617 0121